Carnosine vs GHK-Cu
A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Carnosine
Naturally occurring dipeptide (β-alanine + L-histidine) found at high concentrations in skeletal muscle and brain. Functions as a pH buffer, anti-glycation agent, antioxidant, and metal chelator. Extensively studied for athletic performance (pH buffering), neuroprotection, anti-aging (AGE formation prevention), and cataract research (eye drops).
Full profileGHK-Cu
GHK-Cu is a naturally occurring copper peptide found in human plasma, saliva, and urine. It plays a role in wound healing, skin regeneration, and anti-inflammatory signaling. Levels decline significantly with age, which has driven interest in topical and injectable supplementation.
Full profile| Carnosine | GHK-Cu | |
|---|---|---|
| Category | Anti-Aging & Longevity | Anti-Aging & Longevity |
| Also known as | β-alanyl-L-histidine, L-carnosine, brain dipeptide, muscle dipeptide | Copper Peptide GHK-Cu, Glycyl-L-histidyl-L-lysine copper, Copper Tripeptide-1 |
| Evidence | Research-stage | Research-stage |
| Dosing range | 500mg–2000mg mg, twice daily oral | 1mg–3mg mg, daily to every other day (injectable); twice daily (topical) |
| Administration | Oral (capsule/powder), Topical (eye drops — cataract research) | Subcutaneous injection, Topical application (cream, serum — most common consumer use), Intradermal injection (skincare clinics) |
| Key side effects | Generally well-tolerated, Mild GI discomfort at high doses (>2g/day), Rare: carnosinemia in carnosinase deficiency (genetic condition), Zinc chelation may reduce zinc availability at very high doses | Injection site redness (transient), Mild skin irritation with topical (typically resolves with reduced frequency), Rarely reported: metallic taste (with injectable use at higher doses) |
| Cited sources | 2 references | 4 references |
Key differences
- Administration: Carnosine — Oral (capsule/powder), Topical (eye drops — cataract research); GHK-Cu — Subcutaneous injection, Topical application (cream, serum — most common consumer use), Intradermal injection (skincare clinics).
- Frequency: Carnosine is typically twice daily oral; GHK-Cu is daily to every other day (injectable); twice daily (topical).
- Research depth: this profile cites 2 sources for Carnosine vs 4 for GHK-Cu.
How each works
Carnosine
Carnosine's multi-mechanism activity explains interest across several research domains. Its histidine moiety buffers intramuscular pH during high-intensity exercise, directly improving performance. As an anti-glycation agent, carnosine quenches reactive carbonyl species that form advanced glycation end-products (AGEs), potentially slowing protein crosslinking associated with tissue aging. Brain carnosine concentrations correlate with cognitive vitality in aging research.
GHK-Cu
GHK-Cu has been studied for its ability to stimulate collagen, elastin, and glycosaminoglycan synthesis, promote wound healing, and exhibit antioxidant and anti-inflammatory effects. Gene-expression work by Pickart and colleagues found GHK altered expression (>50% up or down) in roughly 32% of assayed human genes — the basis of the widely-cited '~4,000 genes' figure. Its evidence is strongest for in-vitro and topical/cosmetic use; robust human trials of injectable/systemic GHK-Cu are lacking.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.